ALSO NOTED: Critical Therapeutics closes private placement; Novartis extends cash offer; researchers tout copaxone study; and m

> Critical Therapeutics of Lexington, Mass. has closed on a private placement of $54.5 million. Release

> Novartis has extended its cash tender offer for all public shares of Eon Labs. Article

> Researchers are touting the positive results for copaxone in a four-year study. Release

And finally...Despite a massive ad campaign, most men with erectile dysfunction have never been treated for the condition. Story

Suggested Articles

Sarepta will negotiate a warning for golodirsen rather than carry out more studies. But the implications of the rejection range beyond golodirsen.

The Pfizer Foundation has awarded 20 grants to organizations involved in tackling infectious diseases in low- and middle-income countries.

The engineered stain of E. coli performed no better than placebo, leading Synlogic to conclude its money is better spent on other assets.